Gary Defilipp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Gary Defilipp has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
- Andrew W. Asimos
Department of Emergency Medicine, Neurosciences Institute, Wake Forest University School of Medicine, Advocate Health, Charlotte, NC 28203, USA
6 shared publications - Jeremy B. Rhoten
Neurosciences Institute, Advocate Health, Charlotte, NC 28203, USA
6 shared publications - Rahul R. Karamchandani
Department of Neurology, Neurosciences Institute, Wake Forest University School of Medicine, Advocate Health, Charlotte, NC 28203, USA
6 shared publications - Jonathan D. Clemente
Charlotte Radiology, Neurosciences Institute, Wake Forest University School of Medicine, Advocate Health, Charlotte, NC 28203, USA
5 shared publications - Dale Strong
Clinical Quality Analytics, Advocate Health, Charlotte, NC 28203, USA
4 shared publications - Liang Wang
Clinical Quality Analytics, Advocate Health, Charlotte, NC 28203, USA
4 shared publications
Latest Publications
- Open Access
- 9 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8730
Association of Multimodal Collateral Profiles with Outcomes After Large Core Thrombectomy
Background/Objectives: Cerebral collateral circulation markers in large core thrombectomy and their impact on functional outcomes have not been extensively reported. Methods: We retrospectively analyzed health system medical records of large core (Alberta Stroke Program Early Computed Tomography Score p = 0.889). No significant difference was observed between CCC± and CCC− patients (OR 0.869, 95% CI 0.293–2.577, p = 0.800). Glucose was the only factor independently associated with 90-day outcomes (OR 0.742, 95% CI 0.602–0.915, p = 0.005). Conclusions: No independent association was detected between favorable or mixed cerebral collateral circulation and 90-day mRS 0–3 after large core thrombectomy, though the study was underpowered for the CCC+ comparison. Presenting glucose may inform the likelihood of achieving independent ambulatory status at 90 days.
- 9 November 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (21) , 8730
Open AccessAssociation of Multimodal Collateral Profiles with Outcomes After Large Core Thrombectomy
Background/Objectives: Cerebral collateral circulation markers in large core thrombectomy and their impact on functional outcomes have not been extensively reported. Methods: We retrospectively analyzed health system medical records of large core (Alberta Stroke Program Early Computed Tomography Score p = 0.889). No significant difference was observed between CCC± and CCC− patients (OR 0.869, 95% CI 0.293–2.577, p = 0.800). Glucose was the only factor independently associated with 90-day outcomes (OR 0.742, 95% CI 0.602–0.915, p = 0.005). Conclusions: No independent association was detected between favorable or mixed cerebral collateral circulation and 90-day mRS 0–3 after large core thrombectomy, though the study was underpowered for the CCC+ comparison. Presenting glucose may inform the likelihood of achieving independent ambulatory status at 90 days.
- Open Access
- 15 February 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (4) , 108591
Quality of life after endovascular thrombectomy: A multicenter, prospective, observational study
- 15 February 2026
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 35 (4) , 108591
Open AccessQuality of life after endovascular thrombectomy: A multicenter, prospective, observational study
- Open Access
- 15 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7268
Association of Computed Tomography Perfusion Parameters with 90-Day Functional Independence After Endovascular Thrombectomy
Background/Objectives: Recently, a novel CT perfusion (CTP) parameter, the compensation index (COMPI; ratio of 4 s delayed perfusion to 6 s delayed perfusion), was shown to correlate more strongly with digital subtraction angiographic collaterals than the cerebral blood volume index (CBVI) and hypoperfusion intensity ratio. Methods: We retrospectively analyzed all anterior circulation large vessel occlusion patients treated at multiple thrombectomy centers from January to December 2024 to determine the relationship of COMPI and other CTP parameters with the primary outcome: a 90-day modified Rankin Scale (mRS) score of 0–2. Univariable logistic regression was performed to assess the association between each CTP parameter and the primary outcome in the full cohort and in those achieving endovascular reperfusion (modified treatment in cerebral ischemia 2b-3). Multivariable logistic regression was performed to determine factors independently associated with a 90-day mRS score of 0–2. Results: 323 subjects (median age 69 [57–78] years, median of National Institutes of Health Stroke Scale 15 [10–19.5]) were included, of whom 146/302 (48.3%) were functionally independent at 90 days. The COMPI was not associated with the primary outcome in the univariate analysis. CBVI was the only CTP parameter independently associated with a 90-day mRS score of 0–2 in the full cohort (per 0.1-point increase, odds ratio 1.349, 95% confidence interval 1.099–1.655, p = 0.004) and in those achieving reperfusion. Conclusions: The COMPI was not associated with a 90-day mRS score of 0–2. CBVI was associated with independent neurological function in the full cohort and in reperfused patients, supporting its role as a CTP collateral biomarker and potential risk stratification tool before thrombectomy.
- 15 October 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7268
Open AccessAssociation of Computed Tomography Perfusion Parameters with 90-Day Functional Independence After Endovascular Thrombectomy
Background/Objectives: Recently, a novel CT perfusion (CTP) parameter, the compensation index (COMPI; ratio of 4 s delayed perfusion to 6 s delayed perfusion), was shown to correlate more strongly with digital subtraction angiographic collaterals than the cerebral blood volume index (CBVI) and hypoperfusion intensity ratio. Methods: We retrospectively analyzed all anterior circulation large vessel occlusion patients treated at multiple thrombectomy centers from January to December 2024 to determine the relationship of COMPI and other CTP parameters with the primary outcome: a 90-day modified Rankin Scale (mRS) score of 0–2. Univariable logistic regression was performed to assess the association between each CTP parameter and the primary outcome in the full cohort and in those achieving endovascular reperfusion (modified treatment in cerebral ischemia 2b-3). Multivariable logistic regression was performed to determine factors independently associated with a 90-day mRS score of 0–2. Results: 323 subjects (median age 69 [57–78] years, median of National Institutes of Health Stroke Scale 15 [10–19.5]) were included, of whom 146/302 (48.3%) were functionally independent at 90 days. The COMPI was not associated with the primary outcome in the univariate analysis. CBVI was the only CTP parameter independently associated with a 90-day mRS score of 0–2 in the full cohort (per 0.1-point increase, odds ratio 1.349, 95% confidence interval 1.099–1.655, p = 0.004) and in those achieving reperfusion. Conclusions: The COMPI was not associated with a 90-day mRS score of 0–2. CBVI was associated with independent neurological function in the full cohort and in reperfused patients, supporting its role as a CTP collateral biomarker and potential risk stratification tool before thrombectomy.
- Open Access
- 21 August 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (8) , 130
Validation of the Charlotte Large Artery Occlusion Endovascular Therapy Outcome Score in a Modern Cohort of Thrombectomy Patients
Background/Objectives: The Charlotte Large artery occlusion Endovascular therapy Outcome Score (CLEOS) predicts neurological outcomes after endovascular thrombectomy (EVT). Given recent expanded indications for EVT, we evaluated CLEOS in a modern cohort of thrombectomy patients. Methods: We retrospectively analyzed consecutive, anterior circulation EVT patients from January to December 2024 at multiple centers. The primary outcome was a 90-day modified Rankin Scale (mRS) score of 4–6. We compared primary outcome rates between the original CLEOS derivation cohort and the validation cohort. The area under the curve (AUC) was calculated for CLEOS and compared to other prognostic scales. Results: In the 347 included patients, the mean age was 67.6 (14.9) years, the median National Institutes of Health Stroke Scale (NIHSS) was 15 (10–20), and 137 (42.2%) had a 90-day mRS score of 4–6. A similar proportion of patients in the validation cohort and the derivation cohort achieved the primary outcome (39% each, p = 0.957). The AUC for CLEOS (0.7416, 95% confidence interval [CI] 0.688–0.795) was superior to that of the Pittsburgh Response to Endovascular therapy (AUC 0.681, 95% CI 0.624–0.738, p < 0.01) and Stroke Prognostication using Age and NIHSS (AUC 0.5982, 95% CI 0.556–0.640, p < 0.01), while a trend was observed compared to Houston Intra-Arterial Therapy-2 (AUC 0.6999, 95% CI 0.644–0.756, p = 0.0657) and Totaled Health Risk in Vascular Events (AUC 0.7046, 95% CI 0.560–0.759, p = 0.07). CLEOS ≥ 700 predicted the primary outcome in 16/19 (84.2%) patients. Conclusions: CLEOS performed well in our modern cohort of thrombectomy patients. Prognostic scales such as CLEOS may be useful in guiding conversations and setting expectations with family members pre- and post-thrombectomy.
- 21 August 2025
- Published by MDPI AG in Neurology International
- Vol. 17 (8) , 130
Open AccessValidation of the Charlotte Large Artery Occlusion Endovascular Therapy Outcome Score in a Modern Cohort of Thrombectomy Patients
Background/Objectives: The Charlotte Large artery occlusion Endovascular therapy Outcome Score (CLEOS) predicts neurological outcomes after endovascular thrombectomy (EVT). Given recent expanded indications for EVT, we evaluated CLEOS in a modern cohort of thrombectomy patients. Methods: We retrospectively analyzed consecutive, anterior circulation EVT patients from January to December 2024 at multiple centers. The primary outcome was a 90-day modified Rankin Scale (mRS) score of 4–6. We compared primary outcome rates between the original CLEOS derivation cohort and the validation cohort. The area under the curve (AUC) was calculated for CLEOS and compared to other prognostic scales. Results: In the 347 included patients, the mean age was 67.6 (14.9) years, the median National Institutes of Health Stroke Scale (NIHSS) was 15 (10–20), and 137 (42.2%) had a 90-day mRS score of 4–6. A similar proportion of patients in the validation cohort and the derivation cohort achieved the primary outcome (39% each, p = 0.957). The AUC for CLEOS (0.7416, 95% confidence interval [CI] 0.688–0.795) was superior to that of the Pittsburgh Response to Endovascular therapy (AUC 0.681, 95% CI 0.624–0.738, p < 0.01) and Stroke Prognostication using Age and NIHSS (AUC 0.5982, 95% CI 0.556–0.640, p < 0.01), while a trend was observed compared to Houston Intra-Arterial Therapy-2 (AUC 0.6999, 95% CI 0.644–0.756, p = 0.0657) and Totaled Health Risk in Vascular Events (AUC 0.7046, 95% CI 0.560–0.759, p = 0.07). CLEOS ≥ 700 predicted the primary outcome in 16/19 (84.2%) patients. Conclusions: CLEOS performed well in our modern cohort of thrombectomy patients. Prognostic scales such as CLEOS may be useful in guiding conversations and setting expectations with family members pre- and post-thrombectomy.
- 13 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107931
Early recanalization after tenecteplase versus alteplase: Experience in a large stroke network
- 13 August 2024
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 33 (11) , 107931
Early recanalization after tenecteplase versus alteplase: Experience in a large stroke network